title: Murine model (Galns(tm(C76S)slu)) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins.
abstract: Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive disorder caused by deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS), required for degradation of keratan sulfate and chondroitin-6-sulfate. In order to study the effects of a missense mutation in the active site cysteine in the GALNS gene that is conserved in all mammalian sulfatases, we produced a p.C76S (an active site replacement) knock-in mouse by replacing the Cys76 with Ser in the endogenous murine Galns by targeted mutagenesis. Homozygous Galns(tm(C76S)slu) mice had no detectable GALNS enzyme activity. At age of 2-4 months, lysosomal storage was present primarily within reticuloendothelial cells such as Kupffer cells and spleen sinusoidal lining cells. Vacuolar change was present in glomerular visceral epithelial cells and was not present in hepatocytes or renal tubular cells. In the brain, hippocampal and neocortical neurons and meningeal cells showed lysosomal storage. Radiographs revealed no change in the skeletal bones of mice up to 12 months old. Thus, the Galns(tm(C76S)slu) mice had visceral storage of GAGs in organs but lacked the skeletal features of human MPS IVA. In contrast to a previously reported transgenic model (Galns(tm(hC79S.mC76S)slu)), in which the inactive human GALNS transgene was overexpressed, no reduction in other sulfatases was observed. In addition, the Galns(tm(C76S)slu) mice displayed milder storage. We conclude that the milder phenotype is characteristic of isolated GALNS deficiency while the more severe phenotype reflected in the Galns(tm(hC79S.mC76S)slu) mice was due to deficiency of other sulfatases caused by oversaturation of the sulfate modifying enzyme by the inactive human gene product.
authors.affiliation: Department of Pediatrics, Saint Louis University, Pediatric Research Institute, 3662 Park Ave., St. Louis, MO 63110-2586, USA. tomatsus@slu.edu
authors.forename: Shunji
authors.initials: S
authors.lastname: Tomatsu
authors.forename: Carole
authors.initials: C
authors.lastname: Vogler
authors.forename: Adriana M
authors.initials: AM
authors.lastname: Montaño
authors.forename: Monica
authors.initials: M
authors.lastname: Gutierrez
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Oikawa
authors.forename: Vu Chi
authors.initials: VC
authors.lastname: Dung
authors.forename: Tadao
authors.initials: T
authors.lastname: Orii
authors.forename: Akihiko
authors.initials: A
authors.lastname: Noguchi
authors.forename: William S
authors.initials: WS
authors.lastname: Sly
mesh_terms: D000818:Animals; D001192:Arylsulfatases / Q000378:metabolism; D001665:Binding Sites; D016466:CHO Cells; D002811:Chondroitinsulfatases / Q000235:genetics* / Q000378:metabolism; D006224:Cricetinae; D003412:Cricetulus; D003545:Cysteine / Q000235:genetics*; D004195:Disease Models, Animal; D006801:Humans; D007066:Iduronate Sulfatase / Q000378:metabolism; D008247:Lysosomes / Q000378:metabolism; D051379:Mice; D008817:Mice, Mutant Strains; D009085:Mucopolysaccharidosis IV / Q000235:genetics* / Q000473:pathology; D020125:Mutation, Missense; D009928:Organ Specificity; D010641:Phenotype; D014162:Transfection
chemical_list: D002811:Chondroitinsulfatases; D001192:Arylsulfatases; D007066:Iduronate Sulfatase; C102295:GALNS protein, human; C491158:Galns protein, mouse; D003545:Cysteine